ASX Share rice
Tue 04 Aug 2020 - 09:17:am (Sydney)

ATX Share Price

AMPLIA THERAPEUTICS LIMITEDATXPharmaceuticals, Biotechnology & Life Sciences

ATX Company Information

Name:

Amplia Therapeutics Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

55 Collins Street Melbourne VIC Australia 3000

Phone:

61 2 8003 3650

CEO, MD & Director:

Dr. John Lambert B.Sc., BSc (Hons), MRACI, C.Chem., Ph.D.

Chief Financial Officer:

Mr. Jeff Carter

Company Sec.:

Mr. Andrew John Cooke L.L.B., LLB, FAICS, MAICD, FGIA, FCIS

Chief Scientific Advisor:

Mark Devlin B.Sc., Ph.D.

Founding Scientist:

Dr. Frank Gelder

Company Overview:

Amplia Therapeutics Limited, a pharmaceutical company, focuses on advancing a pipeline of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia. Its clinical development pipeline comprises two lead molecules, AMP945 and AMP886 that inhibits (FAK). The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.

ATX Share Price Information

Shares Issued:

71.85M

Market Capitalisation:

$10.78M

Revenue (TTM):

$34.23K

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.047

Operating Margin (TTM):

$-64.95

Return On Assets (TTM):

$-0.15

Return On Equity (TTM):

$-0.26

Quarterly Revenue Growth (YOY):

-0.961

Gross Profit(TTM):

$-88,991

Diluted Earnings Per Share (TTM):

$-0.046

ATX CashFlow Statement

CashFlow Date:

2020-03-31

Change To Liabilities:

$-16,239

Net Income:

$-2,219,000

Total Cash From Operating Activities:

$-2,087,977

Sale Purchase Of Stock:

$-192,000

Capital Expenditures:

$0

ATX Income Statement

Income Date:

2020-03-31

Income Before Tax:

$-2,219,000

Net Income:

$-2,219,000

Operating Income:

$-2,257,000

ATX Balance Sheet

Balance Sheet Date:

2020-03-31

Intangible Assets:

$7.94M

Total Liabilities:

$511K

Total Stockholder Equity:

$8.61M

Total Assets:

$9.12M

Common Stock:

$132.90M

Other Current Assets:

$70K

Retained Earnings:

$-122,925,000

Cash:

$1.11M

Total Current Liabilities:

$511K

Property - Plant & Equipment:

$797

Net Tangible Assets:

$667.83K

Total Current Assets:

$1.18M

Short-Term Investments:

$7.94M

Accounts Payable:

$511K

Short-Term Investments:

$7.94

Non Current Liabilities Total:

$0

ATX Share Price History

ATX News

30 May, 2020
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
29 Sep, 2019
If you want to know who really controls Amplia Therapeutics Limited (ASX:ATX), then you'll have to look at the makeup...